{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:15:47Z","timestamp":1783984547265,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["964874"],"award-info":[{"award-number":["964874"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41386-025-02054-x","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T13:22:36Z","timestamp":1737206556000},"page":"947-955","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosis"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-4470","authenticated-orcid":false,"given":"Elise","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A.","family":"Shadrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8369-0152","authenticated-orcid":false,"given":"Nadine","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8574-8391","authenticated-orcid":false,"given":"Siobhan K.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-2625","authenticated-orcid":false,"given":"Oleksandr","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-2966","authenticated-orcid":false,"given":"Anders M.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-8061","authenticated-orcid":false,"given":"Srdjan","family":"Djurovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-2751","authenticated-orcid":false,"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"O\u00b4Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-3568","authenticated-orcid":false,"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"2054_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","volume":"74","author":"J Tiihonen","year":"2017","unstructured":"Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtala J, Hoti F, Jedenius E, et al. Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia. JAMA Psychiatry. 2017;74:686\u201393.","journal-title":"JAMA Psychiatry"},{"key":"2054_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939\u201351.","journal-title":"Lancet"},{"key":"2054_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01613-2","volume":"11","author":"E Wagner","year":"2021","unstructured":"Wagner E, Siafis S, Fernando P, Falkai P, Honer WG, Roh A, et al. Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review. Transl Psychiatry. 2021;11:487.","journal-title":"Transl Psychiatry"},{"key":"2054_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.12898","volume":"138","author":"N Myles","year":"2018","unstructured":"Myles N, Myles H, Xia S, Large M, Kisely S, Galletly C, et al. Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatr Scand. 2018;138:101\u20139.","journal-title":"Acta Psychiatr Scand"},{"key":"2054_CR5","doi-asserted-by":"publisher","DOI":"10.1017\/S204579602200066X","volume":"31","author":"E Oloyede","year":"2022","unstructured":"Oloyede E, Blackman G, Whiskey E, Bachmann C, Dzahini O, Shergill S, et al. Clozapine haematological monitoring for neutropenia: a global perspective. Epidemiol Psychiatr Sci. 2022;31:e83.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2054_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jamapsychiatry.2015.2966","volume":"73","author":"JM Kane","year":"2016","unstructured":"Kane JM, Correll CU. The role of clozapine in treatment-resistant schizophrenia. JAMA Psychiatry. 2016;73:187\u20138.","journal-title":"JAMA Psychiatry"},{"key":"2054_CR7","unstructured":"US Food and Drug Administration. Risk Evaluation and Mitigation Strategy (REMS) for clozapine products. 2024. Available from: https:\/\/www.fda.gov\/media\/183654\/download"},{"key":"2054_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/17425255.2021.1974400","volume":"17","author":"E Molden","year":"2021","unstructured":"Molden E. Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies. Expert Opin Drug Metab Toxicol. 2021;17:1211\u201321.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2054_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/tpj.2017.6","volume":"17","author":"SAJ de With","year":"2017","unstructured":"de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA. More than 25 years of genetic studies of clozapine-induced agranulocytosis. Pharmacogenom J. 2017;17:304\u201311.","journal-title":"Pharmacogenom J"},{"key":"2054_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/pgs-2018-0188","volume":"20","author":"SE Legge","year":"2019","unstructured":"Legge SE, Walters JT. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective. Pharmacogenomics. 2019;20:279\u201390.","journal-title":"Pharmacogenomics"},{"key":"2054_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5757","volume":"5","author":"JI Goldstein","year":"2014","unstructured":"Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan L, Fourches D, et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun. 2014;5:4757.","journal-title":"Nat Commun"},{"key":"2054_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/mp.2017.214","volume":"23","author":"SE Legge","year":"2018","unstructured":"Legge SE, Hamshere ML, Ripke S, Pardinas AF, Goldstein JI, Rees E, et al. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Mol Psychiatry. 2018;23:162\u20133.","journal-title":"Mol Psychiatry"},{"key":"2054_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2165\/00003088-199324020-00005","volume":"24","author":"M Jann","year":"1993","unstructured":"Jann M, Grimsley S, Gray E, Chang W. Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet. 1993;24:161\u201376.","journal-title":"Clin Pharmacokinet"},{"key":"2054_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.1365-2125.1997.t01-1-00605.x","volume":"44","author":"B Eiermann","year":"1997","unstructured":"Eiermann B, Engel G, Johansson I, Zanger U, Bertilsson L. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. Br J Clin Pharm. 1997;44:439\u201346.","journal-title":"Br J Clin Pharm"},{"key":"2054_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pharmthera.2007.05.004","volume":"115","author":"J Lameh","year":"2007","unstructured":"Lameh J, Burstein ES, Taylor E, Weiner DM, Vanover KE, Bonhaus DW. Pharmacology of N-desmethylclozapine. Pharm Ther. 2007;115:223\u201331.","journal-title":"Pharm Ther"},{"key":"2054_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.9740\/mhc.2015.03.068","volume":"5","author":"RL Dufresne","year":"2015","unstructured":"Dufresne RL, Ellison JC. A review of the clinical utility of serum clozapine and norclozapine levels. Ment Health Clin. 2015;5:68\u201373.","journal-title":"Ment Health Clin"},{"key":"2054_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/S0022-3565(25)12207-6","volume":"275","author":"Z Liu","year":"1995","unstructured":"Liu Z, Uetrecht J. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J Pharm Exp Ther. 1995;275:1476\u201383.","journal-title":"J Pharm Exp Ther"},{"key":"2054_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","volume":"7","author":"M Pirmohamed","year":"1997","unstructured":"Pirmohamed M, Park K. Mechanism of clozapine-induced agranulocytosis. CNS Drugs. 1997;7:139\u201358.","journal-title":"CNS Drugs"},{"key":"2054_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40263-017-0469-1","volume":"31","author":"RL Smith","year":"2017","unstructured":"Smith RL, Haslemo T, Andreassen OA, Eliasson E, Dahl ML, Spigset O, et al. Correlation between serum concentrations of N-desmethylclozapine and granulocyte levels in patients with schizophrenia: a retrospective observational study. CNS Drugs. 2017;31:991\u20137.","journal-title":"CNS Drugs"},{"key":"2054_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.658734","volume":"12","author":"IR Willcocks","year":"2021","unstructured":"Willcocks IR, Legge SE, Nalmpanti M, Mazzeo L, King A, Jansen J, et al. Clozapine metabolism is associated with absolute neutrophil count in individuals with treatment-resistant schizophrenia. Front Pharm. 2021;12:658734.","journal-title":"Front Pharm"},{"key":"2054_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S2215-0366(23)00002-0","volume":"10","author":"AF Pardinas","year":"2023","unstructured":"Pardinas AF, Kappel DB, Roberts M, Tipple F, Shitomi-Jones LM, King A, et al. Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: a longitudinal analysis and genome-wide association study using UK clinical monitoring data. Lancet Psychiatry. 2023;10:209\u201319.","journal-title":"Lancet Psychiatry"},{"key":"2054_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","volume":"182","author":"D Vuckovic","year":"2020","unstructured":"Vuckovic D, Bao EL, Akbari P, Lareau CA, Mousas A, Jiang T, et al. The polygenic and monogenic basis of blood traits and diseases. Cell. 2020;182:1214\u2013231.e1211.","journal-title":"Cell"},{"key":"2054_CR23","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","volume":"182","author":"MH Chen","year":"2020","unstructured":"Chen MH, Raffield LM, Mousas A, Sakaue S, Huffman JE, Moscati A, et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182:1198\u2013213.e1114.","journal-title":"Cell"},{"key":"2054_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/schbul\/sbt168","volume":"40","author":"OA Andreassen","year":"2014","unstructured":"Andreassen OA, Thompson WK, Dale AM. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr Bull. 2014;40:13\u20137.","journal-title":"Schizophr Bull"},{"key":"2054_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ajhg.2013.01.001","volume":"92","author":"OA Andreassen","year":"2013","unstructured":"Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O\u2019Donovan MC, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92:197\u2013209.","journal-title":"Am J Hum Genet"},{"key":"2054_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00439-019-02060-2","volume":"139","author":"OB Smeland","year":"2020","unstructured":"Smeland OB, Frei O, Shadrin A, O\u2019Connell K, Fan CC, Bahrami S, et al. Discovery of shared genomic loci using the conditional false discovery rate approach. Hum Genet. 2020;139:85\u201394.","journal-title":"Hum Genet"},{"key":"2054_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.","journal-title":"Nat Commun"},{"key":"2054_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"2054_CR29","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790\u20137.","journal-title":"Genome Res"},{"key":"2054_CR30","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005\u2013D1012.","journal-title":"Nucleic Acids Res"},{"key":"2054_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"Consortium G.","year":"2015","unstructured":"Consortium G. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648\u201360.","journal-title":"Science"},{"key":"2054_CR32","doi-asserted-by":"publisher","first-page":"D1311","DOI":"10.1093\/nar\/gkaa840","volume":"49","author":"M Ghoussaini","year":"2021","unstructured":"Ghoussaini M, Mountjoy E, Carmona M, Peat G, Schmidt EM, Hercules A, et al. Open targets genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2021;49:D1311\u2013D1320.","journal-title":"Nucleic Acids Res"},{"key":"2054_CR33","doi-asserted-by":"publisher","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","volume":"52","author":"M Cannon","year":"2024","unstructured":"Cannon M, Stevenson J, Stahl K, Basu R, Coffman A, Kiwala S, et al. DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 2024;52:D1227\u2013D1235.","journal-title":"Nucleic Acids Res"},{"key":"2054_CR34","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:1\u201329.","DOI":"10.7554\/eLife.34408"},{"key":"2054_CR35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365.","journal-title":"Genet Epidemiol"},{"key":"2054_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"2054_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"2054_CR38","doi-asserted-by":"crossref","unstructured":"Choi SW, O\u2019Reilly PF. PRSice-2: Polygenic Risk Score software for biobank-scale data. Gigascience. 2019;8:1\u20136.","DOI":"10.1093\/gigascience\/giz082"},{"key":"2054_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2022.100570","volume":"3","author":"AH Ramirez","year":"2022","unstructured":"Ramirez AH, Sulieman L, Schlueter DJ, Halvorson A, Qian J, Ratsimbazafy F, et al. The All of Us research program: data quality, utility, and diversity. Patterns. 2022;3:100570.","journal-title":"Patterns"},{"key":"2054_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/hmg\/ddy327","volume":"28","author":"SL Pulit","year":"2019","unstructured":"Pulit SL, Stoneman C, Morris AP, Wood AR, Glastonbury CA, Tyrrell J, et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet. 2019;28:166\u201374.","journal-title":"Hum Mol Genet"},{"key":"2054_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41588-017-0011-x","volume":"50","author":"V Turcot","year":"2018","unstructured":"Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018;50:26\u201341.","journal-title":"Nat Genet"},{"key":"2054_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2018.11.008","volume":"104","author":"G Kichaev","year":"2019","unstructured":"Kichaev G, Bhatia G, Loh PR, Gazal S, Burch K, Freund MK, et al. Leveraging polygenic functional enrichment to improve GWAS power. Am J Hum Genet. 2019;104:65\u201375.","journal-title":"Am J Hum Genet"},{"key":"2054_CR43","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415\u201324.","journal-title":"Nat Genet"},{"key":"2054_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jaci.2019.09.035","volume":"145","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Guo Y, Shi H, Liu CL, Panganiban RA, Chung W, et al. Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank. J Allergy Clin Immunol. 2020;145:537\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"2054_CR45","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/ng.3951","volume":"49","author":"M Akiyama","year":"2017","unstructured":"Akiyama M, Okada Y, Kanai M, Takahashi A, Momozawa Y, Ikeda M, et al. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat Genet. 2017;49:1458\u201367.","journal-title":"Nat Genet"},{"key":"2054_CR46","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2337\/db21-0129","volume":"70","author":"S Martin","year":"2021","unstructured":"Martin S, Cule M, Basty N, Tyrrell J, Beaumont RN, Wood AR, et al. Genetic evidence for different adiposity phenotypes and their opposing influences on ectopic fat and risk of cardiometabolic disease. Diabetes. 2021;70:1843\u201356.","journal-title":"Diabetes"},{"key":"2054_CR47","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","volume":"53","author":"AR Barton","year":"2021","unstructured":"Barton AR, Sherman MA, Mukamel RE, Loh PR. Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses. Nat Genet. 2021;53:1260\u20139.","journal-title":"Nat Genet"},{"key":"2054_CR48","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2217\/pgs.15.61","volume":"16","author":"H Visscher","year":"2015","unstructured":"Visscher H, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, et al. Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics. 2015;16:1065\u201376.","journal-title":"Pharmacogenomics"},{"key":"2054_CR49","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415\u201329.e1419.","journal-title":"Cell"},{"key":"2054_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, Worheide MA, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374:eabj1541.","journal-title":"Science"},{"key":"2054_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","volume":"52","author":"M Bharadwaj","year":"2012","unstructured":"Bharadwaj M, Illing P, Theodossis A, Purcell AW, Rossjohn J, McCluskey J. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu Rev Pharm Toxicol. 2012;52:401\u201331.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"2054_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/FPC.0000000000000124","volume":"25","author":"EM Cornejo Castro","year":"2015","unstructured":"Cornejo Castro EM, Carr DF, Jorgensen AL, Alfirevic A, Pirmohamed M. HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis. Pharmacogenet Genom. 2015;25:186\u201398.","journal-title":"Pharmacogenet Genom"},{"key":"2054_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41537-023-00404-6","volume":"9","author":"SK Lock","year":"2023","unstructured":"Lock SK, Legge SE, Kappel DB, Willcocks IR, Helthuis M, Jansen J, et al. Mediation and longitudinal analysis to interpret the association between clozapine pharmacokinetics, pharmacogenomics, and absolute neutrophil count. Schizophrenia. 2023;9:74.","journal-title":"Schizophrenia"},{"key":"2054_CR54","doi-asserted-by":"crossref","unstructured":"van der Meer D, Shadrin AA, O\u2019Connell K, Bettella F, Djurovic S, Wolfers T, et al. Boosting schizophrenia genetics by utilizing genetic overlap with brain morphology. Biol Psychiatry. 2022,9:291\u2013298.","DOI":"10.1016\/j.biopsych.2021.12.007"},{"key":"2054_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115217","volume":"325","author":"KS O\u2019Connell","year":"2023","unstructured":"O\u2019Connell KS, Koch E, Lenk HC, Akkouh IA, Hindley G, Jaholkowski P, et al. Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia. Psychiatry Res. 2023;325:115217.","journal-title":"Psychiatry Res"},{"key":"2054_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41397-022-00281-9","volume":"22","author":"F Islam","year":"2022","unstructured":"Islam F, Hain D, Lewis D, Law R, Brown LC, Tanner JA, et al. Pharmacogenomics of clozapine-induced agranulocytosis: a systematic review and meta-analysis. Pharmacogenom. J. 2022;22:230\u201340.","journal-title":"Pharmacogenom. J"},{"key":"2054_CR57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41380-018-0335-7","volume":"24","author":"SE Legge","year":"2019","unstructured":"Legge SE, Pardinas AF, Helthuis M, Jansen JA, Jollie K, Knapper S, et al. A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Mol Psychiatry. 2019;24:328\u201337.","journal-title":"Mol Psychiatry"},{"key":"2054_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03080-8","volume":"9","author":"M Massara","year":"2018","unstructured":"Massara M, Bonavita O, Savino B, Caronni N, Mollica Poeta V, Sironi M, et al. ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity. Nat Commun. 2018;9:676.","journal-title":"Nat Commun"},{"key":"2054_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1389200223666220201152953","volume":"23","author":"RL Smith","year":"2022","unstructured":"Smith RL, Wollmann BM, Kausberg M, M\u00e6land S, Tveito M, O\u2019Connell K, et al. Effects of a novel UGT2B haplotype and UGT1A4*3 allele variants on glucuronidation of clozapine in vivo. Curr Drug Metab. 2022;23:66\u201372.","journal-title":"Curr Drug Metab"},{"key":"2054_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00004850-200505000-00007","volume":"20","author":"CH Ng","year":"2005","unstructured":"Ng CH, Chong SA, Lambert T, Fan A, Hackett LP, Mahendran R, et al. An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels. Int Clin Psychopharmacol. 2005;20:163\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"2054_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1192\/bjp.175.6.576","volume":"175","author":"J Munro","year":"1999","unstructured":"Munro J, O\u2019Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999;175:576\u201380.","journal-title":"Br J Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02054-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:01:46Z","timestamp":1745582506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02054-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02054-x","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"OAA reported grants from Stiftelsen Kristian Gerhard Jebsen, South-East Regional Health Authority, Research Council of Norway, and European Union\u2019s Horizon 2020 during the conduct of the study; personal fees from cortechs.ai (stock options), Lundbeck (speaker\u2019s honorarium), and Sunovion (speaker\u2019s honorarium) and Janssen (speaker\u2019s honorarium) outside the submitted work. AMD was a Founder of and holds equity in CorTechs Labs, Inc., and serves on its Scientific Advisory Board. He is also a member of the Scientific Advisory Board of Human Longevity, Inc. (HLI), and the Mohn Medical Imaging and Visualization Centre in Bergen, Norway. He receives funding through a research agreement with General Electric Healthcare (GEHC). The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. All other authors report no financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}